173 related articles for article (PubMed ID: 31806527)
1. The long-term antipsychotic treatment of schizophrenia: A selective review of clinical guidelines and clinical case examples.
Gaebel W; Stricker J; Riesbeck M
Schizophr Res; 2020 Nov; 225():4-14. PubMed ID: 31806527
[TBL] [Abstract][Full Text] [Related]
2. TAILOR - tapered discontinuation versus maintenance therapy of antipsychotic medication in patients with newly diagnosed schizophrenia or persistent delusional disorder in remission of psychotic symptoms: study protocol for a randomized clinical trial.
Stürup AE; Jensen HD; Dolmer S; Birk M; Albert N; Nielsen M; Hjorthøj C; Eplov L; Ebdrup BH; Mors O; Nordentoft M
Trials; 2017 Sep; 18(1):445. PubMed ID: 28962668
[TBL] [Abstract][Full Text] [Related]
3. Antipsychotic treatment for schizophrenia in the maintenance phase: a systematic review of the guidelines and algorithms.
Takeuchi H; Suzuki T; Uchida H; Watanabe K; Mimura M
Schizophr Res; 2012 Feb; 134(2-3):219-25. PubMed ID: 22154594
[TBL] [Abstract][Full Text] [Related]
4. [Neuroleptic low-dose long-term strategy and intermittent therapy strategy in chronic schizophrenia--a critical review].
Hofmann P; Melisch B; Zapotoczky HG; Kulhanek F
Fortschr Neurol Psychiatr; 1993 Jun; 61(6):195-200. PubMed ID: 8101177
[TBL] [Abstract][Full Text] [Related]
5. Antipsychotic treatment in the maintenance phase of schizophrenia: An updated systematic review of the guidelines and algorithms.
Shimomura Y; Kikuchi Y; Suzuki T; Uchida H; Mimura M; Takeuchi H
Schizophr Res; 2020 Jan; 215():8-16. PubMed ID: 31784340
[TBL] [Abstract][Full Text] [Related]
6. Beyond Clinical Remission in First Episode Psychosis: Thoughts on Antipsychotic Maintenance vs. Guided Discontinuation in the Functional Recovery Era.
Alvarez-Jimenez M; O'Donoghue B; Thompson A; Gleeson JF; Bendall S; Gonzalez-Blanch C; Killackey E; Wunderink L; McGorry PD
CNS Drugs; 2016 May; 30(5):357-68. PubMed ID: 27106296
[TBL] [Abstract][Full Text] [Related]
7. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I
Encephale; 2005; 31(2):235-46. PubMed ID: 15959450
[TBL] [Abstract][Full Text] [Related]
8. Early, targeted pharmacotherapeutic intervention in schizophrenia.
Carpenter W
J Clin Psychiatry; 1986 May; 47 Suppl():23-9. PubMed ID: 2871012
[TBL] [Abstract][Full Text] [Related]
9. The Long-Term Effects of Antipsychotic Medication on Clinical Course in Schizophrenia.
Goff DC; Falkai P; Fleischhacker WW; Girgis RR; Kahn RM; Uchida H; Zhao J; Lieberman JA
Am J Psychiatry; 2017 Sep; 174(9):840-849. PubMed ID: 28472900
[TBL] [Abstract][Full Text] [Related]
10. Atypical antipsychotics for psychosis in adolescents.
Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
[TBL] [Abstract][Full Text] [Related]
11. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
12. Antipsychotic dose in maintenance treatment of schizophrenia: A retrospective study.
Kumar V; Rao NP; Narasimha V; Sathyanarayanan G; Muralidharan K; Varambally S; Venkatasubramanian G; Gangadhar BN
Psychiatry Res; 2016 Nov; 245():311-316. PubMed ID: 27567194
[TBL] [Abstract][Full Text] [Related]
13. Penfluridol for schizophrenia.
Soares BG; Lima MS
Cochrane Database Syst Rev; 2006 Apr; (2):CD002923. PubMed ID: 16625563
[TBL] [Abstract][Full Text] [Related]
14. Maintenance therapy in schizophrenia: a critical comment.
Chan SS; Ungvari GS
Int J Neuropsychopharmacol; 2002 Sep; 5(3):277-81. PubMed ID: 12366880
[TBL] [Abstract][Full Text] [Related]
15. The revised DGPPN and APA schizophrenia guidelines: Guideline quality and recommendations for long-term antipsychotic treatment.
Gaebel W; Stricker J; Hasan A; Falkai P; McIntyre JS; Kerst A
Schizophr Res; 2021 Mar; 229():137-139. PubMed ID: 33203610
[No Abstract] [Full Text] [Related]
16. Antipsychotic medication in the treatment of schizophrenia.
Kane JM
Isr J Psychiatry Relat Sci; 1995; 32(1):30-7. PubMed ID: 7542642
[TBL] [Abstract][Full Text] [Related]
17. Weighing the evidence for harm from long-term treatment with antipsychotic medications: A systematic review.
Sohler N; Adams BG; Barnes DM; Cohen GH; Prins SJ; Schwartz S
Am J Orthopsychiatry; 2016; 86(5):477-85. PubMed ID: 26652608
[TBL] [Abstract][Full Text] [Related]
18. First-episode schizophrenia. Early intervention and medication discontinuation in the context of course and treatment.
Wyatt RJ; Damiani LM; Henter ID
Br J Psychiatry Suppl; 1998; 172(33):77-83. PubMed ID: 9764131
[TBL] [Abstract][Full Text] [Related]
19. Maintenance treatment with antipsychotic drugs for schizophrenia.
Leucht S; Tardy M; Komossa K; Heres S; Kissling W; Davis JM
Cochrane Database Syst Rev; 2012 May; (5):CD008016. PubMed ID: 22592725
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness analysis of switching antipsychotic medication to long-acting injectable risperidone in patients with schizophrenia : a 12- and 24-month follow-up from the e-STAR database in Spain.
Olivares JM; Rodriguez-Martinez A; Burón JA; Alonso-Escolano D; Rodriguez-Morales A;
Appl Health Econ Health Policy; 2008; 6(1):41-53. PubMed ID: 18774869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
